JP7832424B2 - 特定の立体構造を誘導する人工核酸 - Google Patents

特定の立体構造を誘導する人工核酸

Info

Publication number
JP7832424B2
JP7832424B2 JP2023540349A JP2023540349A JP7832424B2 JP 7832424 B2 JP7832424 B2 JP 7832424B2 JP 2023540349 A JP2023540349 A JP 2023540349A JP 2023540349 A JP2023540349 A JP 2023540349A JP 7832424 B2 JP7832424 B2 JP 7832424B2
Authority
JP
Japan
Prior art keywords
nucleic acid
complementary
domain
sequence
dimensional structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023540349A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023013613A5 (https=
JPWO2023013613A1 (https=
Inventor
次郎 近藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sophia School Corp
Original Assignee
Sophia School Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sophia School Corp filed Critical Sophia School Corp
Publication of JPWO2023013613A1 publication Critical patent/JPWO2023013613A1/ja
Publication of JPWO2023013613A5 publication Critical patent/JPWO2023013613A5/ja
Application granted granted Critical
Publication of JP7832424B2 publication Critical patent/JP7832424B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023540349A 2021-08-02 2022-08-01 特定の立体構造を誘導する人工核酸 Active JP7832424B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021126578 2021-08-02
JP2021126578 2021-08-02
PCT/JP2022/029566 WO2023013613A1 (ja) 2021-08-02 2022-08-01 特定の立体構造を誘導する人工核酸

Publications (3)

Publication Number Publication Date
JPWO2023013613A1 JPWO2023013613A1 (https=) 2023-02-09
JPWO2023013613A5 JPWO2023013613A5 (https=) 2024-04-23
JP7832424B2 true JP7832424B2 (ja) 2026-03-18

Family

ID=85155666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023540349A Active JP7832424B2 (ja) 2021-08-02 2022-08-01 特定の立体構造を誘導する人工核酸

Country Status (4)

Country Link
US (1) US20250346892A1 (https=)
EP (1) EP4382603A4 (https=)
JP (1) JP7832424B2 (https=)
WO (1) WO2023013613A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202304740D0 (en) * 2023-03-30 2023-05-17 Chancellor Masters And Scholars Of The Univ Of Oxford Rna silencing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333698T2 (de) * 1992-07-20 2005-12-01 Isis Pharmaceutical, Inc., Carlsbad Pseudo-halbknoten ausbildende rna durch hybridisierung von antisenseoligonnukleotiden an gezielte rna sekundärstrukturen
JP7153113B2 (ja) 2019-09-16 2022-10-13 株式会社藤商事 遊技機

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Mol. Ther.，2011年，Vol. 19, No. 9，p. 1676-1687
Nucleic Acids Res.，2012年，Vol. 30, No.3，p. 830-837
Nucleic Acids Res.，2012年，Vol. 40, No. 3，p. 1307-1317
Virol. J.，2021年02月，Vol. 18:37，p. 1-10
かやのもり：近畿大学産業理工学部，2016年，第25号，p. 1-6

Also Published As

Publication number Publication date
EP4382603A1 (en) 2024-06-12
JPWO2023013613A1 (https=) 2023-02-09
EP4382603A4 (en) 2025-10-15
US20250346892A1 (en) 2025-11-13
WO2023013613A1 (ja) 2023-02-09

Similar Documents

Publication Publication Date Title
US12344841B2 (en) Chimeric double-stranded nucleic acid
Seok et al. Position-specific oxidation of miR-1 encodes cardiac hypertrophy
Kaur et al. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA)
Petersen et al. LNA: a versatile tool for therapeutics and genomics
Rapireddy et al. Strand invasion of mixed-sequence, double-helical B-DNA by γ-peptide nucleic acids containing G-clamp nucleobases under physiological conditions
Zhang et al. Topologically constrained formation of stable Z-DNA from normal sequence under physiological conditions
US9206419B2 (en) Targeting domain and related signal activated molecular delivery
AU2009302385B2 (en) Telomerase inhibitors and methods of use thereof
AU2012322788A1 (en) Micrornas in neurodegenerative disorders
Karunatilaka et al. Post-transcriptional modifications modulate conformational dynamics in human U2–U6 snRNA complex
US9278108B2 (en) HMGB1 binding nucleic acid molecule and applications thereof
Kiliszek et al. Crystallographic characterization of CCG repeats
JP7832424B2 (ja) 特定の立体構造を誘導する人工核酸
Chen et al. Solution structure of an RNA internal loop with three consecutive sheared GA pairs
Abibi et al. Specific versus nonspecific binding of cationic PNAs to duplex DNA
US11174505B2 (en) Simple one-step real-time molecular system for microRNA detection
CN118647722A (zh) Fgg相关疾病和病症的治疗
Ren et al. A general strategy for engineering GU base pairs to facilitate RNA crystallization
WO2021158589A1 (en) Treatment of ophthalmic conditions with son of sevenless 2 (sos2) inhibitors
Davis et al. Positional and neighboring base pair effects on the thermodynamic stability of RNA single mismatches
Wan et al. High-Resolution NMR Structures of Intrastrand Hairpins Formed by CTG Trinucleotide Repeats
WO1993005180A1 (en) Formation of triple helix complexes of double stranded dna using nucleoside oligomers which comprise purine base analogs
Tomaszewska-Antczak et al. Acyclic Nucleic Acids with Phosphodiester Linkages—Synthesis, Properties and Potential Applications
US20040029160A1 (en) Parallel stranded duplexes of deoxyribonucleic acid and methods of use
Huppert Studies on genomic G-quadruplexes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240130

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20240130

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20240130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250114

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260116

R150 Certificate of patent or registration of utility model

Ref document number: 7832424

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150